Beigene Ltd Company Profile (NASDAQ:BGNE)

About Beigene Ltd

Beigene Ltd logoBeiGene, Ltd. is a biopharmaceutical company. The Company is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. It is developing its product candidate, BGB-3111, a potent and selective small molecule Bruton's tyrosine kinase (BTK) inhibitor, as a monotherapy and in combination with other therapies for the treatment of a range of lymphomas. It is developing its product candidate, BGB-A317, a humanized monoclonal antibody against the immune checkpoint receptor programmed cell death protein 1 (PD-1), as a monotherapy and as a combination agent for various solid-organ and blood-borne cancers. It is developing BGB-290, a molecularly targeted, orally available, potent and selective inhibitor of poly ADP ribose polymerase 1 (PARP1) and PARP2, as a monotherapy and in combination with other therapies for the treatment of homologous recombination deficient cancers. It is also developing BGB-283 for the treatment of cancers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BGNE
  • CUSIP:
Key Metrics:
  • Previous Close: $31.18
  • 50 Day Moving Average: $29.56
  • 200 Day Moving Average: $29.01
  • 52-Week Range: $32,903,000.00 - $22.51
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.30
  • P/E Growth: 0.00
  • Market Cap: $1.00B
  • Outstanding Shares: 32,903,000
Additional Links:
Companies Related to Beigene Ltd:

Analyst Ratings

Consensus Ratings for Beigene Ltd (NASDAQ:BGNE) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $40.00 (31.19% upside)

Analysts' Ratings History for Beigene Ltd (NASDAQ:BGNE)
Show:
DateFirmActionRatingPrice TargetDetails
9/21/2016Maxim GroupInitiated CoverageBuy$41.00View Rating Details
6/6/2016Cowen and CompanyReiterated RatingBuyView Rating Details
4/8/2016Morgan StanleyBoost Price Target$39.00 -> $42.00View Rating Details
2/29/2016Robert W. BairdInitiated CoverageOutperform$44.00View Rating Details
2/29/2016Goldman Sachs Group Inc.Initiated CoverageBuy$33.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Beigene Ltd (NASDAQ:BGNE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2016Q2($0.68)($0.73)$2.08 million$0.40 millionViewN/AView Earnings Details
5/11/2016Q1($0.05)($0.97)$0.70 millionViewN/AView Earnings Details
3/30/2016Q4($1.06)($3.05)$1.74 million$4.68 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Beigene Ltd (NASDAQ:BGNE)
Current Year EPS Consensus Estimate: $-3.38 EPS
Next Year EPS Consensus Estimate: $-3.28 EPS

Dividends

Dividend History for Beigene Ltd (NASDAQ:BGNE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Beigene Ltd (NASDAQ:BGNE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/21/2016Donald W GlazerDirectorSell67,252$31.42$2,113,057.84View SEC Filing  
2/8/2016Bros. Advisors Lp BakerDirectorBuy1,912,680$24.00$45,904,320.00View SEC Filing  
2/8/2016Howard LiangCFOBuy65,000$1.85$120,250.00View SEC Filing  
2/8/2016Ruirong YuanInsiderBuy130,000$1.85$240,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Beigene Ltd (NASDAQ:BGNE)
DateHeadline
finance.yahoo.com logoCoverage initiated on BeiGene by Maxim Group (NASDAQ:BGNE)
finance.yahoo.com - September 22 at 3:57 PM
publicnow.com logoBeiGene Receives Approval to Initiate Clinical Trials in China with PD-1 Antibody BGB-A317 (NASDAQ:BGNE)
www.publicnow.com - September 15 at 12:45 PM
finance.yahoo.com logoBeiGene (BGNE) Catches Eye: Stock Adds 6% in Session (NASDAQ:BGNE)
finance.yahoo.com - September 15 at 12:45 PM
publicnow.com logoBeiGene Appoints Jane Huang, M.D. as Chief Medical Officer, Hematology (NASDAQ:BGNE)
www.publicnow.com - September 6 at 8:39 PM
finance.yahoo.com logoBeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences (NASDAQ:BGNE)
finance.yahoo.com - September 1 at 12:15 PM
News IconMedivation Exec Jumps Ship to Become CMO at BeiGene (NASDAQ:BGNE)
www.biospace.com - August 26 at 11:54 AM
publicnow.com logoBeiGene Appoints Amy Peterson, M.D. as Chief Medical Officer, Immuno-oncology (NASDAQ:BGNE)
www.publicnow.com - August 25 at 8:40 AM
investing.com logoBeiGene Approved To Start Clinical Trials In China (NASDAQ:BGNE)
www.investing.com - August 23 at 5:29 AM
streetinsider.com logoBeiGene (BGNE) Approved by China FDA to Commence BGB-290 Clinical Trials (NASDAQ:BGNE)
www.streetinsider.com - August 18 at 9:19 PM
publicnow.com logoBeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290 (NASDAQ:BGNE)
www.publicnow.com - August 18 at 12:13 PM
publicnow.com logoBeiGene Reports Second Quarter 2016 Financial Results (NASDAQ:BGNE)
www.publicnow.com - August 10 at 9:16 PM
fxpips.com logoTop Gainers, Losers in Manufacturing Sector Today (NASDAQ:BGNE)
www.fxpips.com - July 23 at 8:03 AM
publicnow.com logoBeiGene Announces First Patient Dosing for Investigational BTK Inhibitor BGB-3111 in China (NASDAQ:BGNE)
www.publicnow.com - July 5 at 4:41 PM
reuters.com logoProfile: BeiGene Ltd (BGNE.OQ) (NASDAQ:BGNE)
www.reuters.com - July 3 at 8:33 AM
News IconHavre de Grace’s Independence Celebrations set for this weekend (NASDAQ:BGNE)
www.cecildaily.com - July 1 at 8:59 PM
News IconBaltimore Hospital finds alternative medevac site (NASDAQ:BGNE)
www.airmedandrescue.com - July 1 at 8:59 PM
News IconAll Food Will be Local For First Time in Artscape History (NASDAQ:BGNE)
www.baltimoremagazine.net - July 1 at 8:59 PM
News IconCelebrate Independence Day at the Inner Harbor (NASDAQ:BGNE)
baltimorepostexaminer.com - July 1 at 8:59 PM
News IconThe Arc Baltimore Names BGE's Larry Burley to its Board of Directors (NASDAQ:BGNE)
patch.com - July 1 at 8:59 PM
marketexclusive.com logoBeigene Ltd (NASDAQ:BGNE) Doses First Patient In Combination Trial Of BGB-A317 and BGB-3111 (NASDAQ:BGNE)
marketexclusive.com - July 1 at 8:59 PM
News IconBGE restores ospreys' home after a lighting strike destroys their nest (NASDAQ:BGNE)
www.abc2news.com - July 1 at 8:59 PM
News IconBGE Inks Medevac Helicopter Deal with Baltimore Hospital (NASDAQ:BGNE)
baltimore.cbslocal.com - July 1 at 8:59 PM
News IconBGE customers can join texting program for outages (NASDAQ:BGNE)
www.baltimoresun.com - July 1 at 8:59 PM
publicnow.com logoBeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317 (NASDAQ:BGNE)
www.publicnow.com - June 29 at 4:51 PM
uk.finance.yahoo.com logoU.S. regulator says too many drugmakers chasing same cancer strategy (NASDAQ:BGNE)
uk.finance.yahoo.com - June 14 at 4:44 PM
publicnow.com logoBeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting (NASDAQ:BGNE)
www.publicnow.com - June 5 at 9:08 AM
publicnow.com logoBeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting (NASDAQ:BGNE)
www.publicnow.com - May 19 at 6:52 AM
biz.yahoo.com logoBEIGENE, LTD. Files SEC form 10-Q, Quarterly Report (NASDAQ:BGNE)
biz.yahoo.com - May 12 at 4:25 PM
publicnow.com logoBeiGene Reports First Quarter 2016 Financial Results (NASDAQ:BGNE)
www.publicnow.com - May 11 at 5:07 PM
publicnow.com logoBeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development (NASDAQ:BGNE)
www.publicnow.com - May 4 at 5:41 PM
wsj.com logoChinese Commodities Brokerage Yintech Debuts on Nasdaq (NASDAQ:BGNE)
www.wsj.com - April 28 at 8:03 AM
finance.yahoo.com logoOpening Bell, April 21, 2016 (NASDAQ:BGNE)
finance.yahoo.com - April 21 at 9:30 AM
publicnow.com logoBeiGene (Nasdaq: BGNE) to Ring The Nasdaq Stock Market Opening Bell (NASDAQ:BGNE)
www.publicnow.com - April 20 at 10:21 AM
capitalcube.com logoBeiGene Ltd. :BGNE-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:BGNE)
www.capitalcube.com - April 19 at 9:26 AM
News IconThe 11 year-old Dancing Trumps from Fiske Elementary School in Wellesley, Massachusetts were banned from entering the talent show (NASDAQ:BGNE)
www.ad-hoc-news.de - April 18 at 7:44 AM
biz.yahoo.com logoBEIGENE, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:BGNE)
biz.yahoo.com - April 18 at 7:40 AM
publicnow.com logoBeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting (NASDAQ:BGNE)
www.publicnow.com - April 17 at 5:26 PM
biz.yahoo.com logoBEIGENE, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati (NASDAQ:BGNE)
biz.yahoo.com - April 11 at 5:10 PM
finance.yahoo.com logoBeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer (NASDAQ:BGNE)
finance.yahoo.com - April 11 at 5:00 PM
finance.yahoo.com logoBEIGENE, LTD. Financials (NASDAQ:BGNE)
finance.yahoo.com - April 5 at 1:04 PM
nasdaq.com logoWith Biotechnology Companies Leading the Way, Six Venture-Backed IPOs Recorded in First Quarter (NASDAQ:BGNE)
www.nasdaq.com - April 4 at 4:45 PM
nasdaq.com logoEarnings Reported After The Bell Mar.30 (NASDAQ:BGNE)
www.nasdaq.com - March 31 at 7:23 AM
biz.yahoo.com logoBEIGENE, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BGNE)
biz.yahoo.com - March 30 at 4:24 PM
finance.yahoo.com logoBeiGene Reports Fourth Quarter and Full Year 2015 Financial Results (NASDAQ:BGNE)
finance.yahoo.com - March 30 at 4:05 PM
biz.yahoo.com logoBEIGENE, LTD. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:BGNE)
biz.yahoo.com - March 29 at 4:17 PM
finance.yahoo.com logoBeiGene Announces Presentations on BGB-283 and Other Pipeline Agents at the 2016 American Association for Cancer Research Annual Meeting (NASDAQ:BGNE)
finance.yahoo.com - March 16 at 5:48 PM
finance.yahoo.com logo8:02 am BeiGene recieves clinical trial application approval from CFDA to conduct clinical trials with BGB-3111 (NASDAQ:BGNE)
finance.yahoo.com - March 7 at 8:02 AM
finance.yahoo.com logoBeiGene Receives Approval to Initiate Clinical Trials in China With BGB-3111 (NASDAQ:BGNE)
finance.yahoo.com - March 7 at 8:00 AM
insidermonkey.com logoBill Gates’ Cascade Investment Boosts AutoNation Inc. (AN) Stake, Buffett Keeps Buying Phillips 66 (PSX), Plus Baker Bros.’ Latest Move (NASDAQ:BGNE)
www.insidermonkey.com - February 10 at 12:39 PM
forbes.com logoLittle Hope For IPO Recovery In First Quarter (NASDAQ:BGNE)
www.forbes.com - February 9 at 11:04 AM

Social

Beigene Ltd (NASDAQ:BGNE) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff